HEALTH DEPARTMENT
Biovac Institute may be shut out of R12bn state tender
01 August 2019 - 05:10
Biovac Institute, the state-backed exclusive supplier of childhood immunisations to the government, could be shut out of its next R12bn tender, threatening its viability and putting more than 300 jobs on the line.
Biovac is a public-private partnership that was founded in 2003 to revive SA’s human vaccine manufacturing capacity. It is 47.5% owned by the government and the remaining stake is held by a private biotech consortium led by Immunotek...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.